Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2007

Sep 4, 2007

30339_dirs_2007-09-04_9d5e3c8f-94ee-4d93-802f-b548880cb844.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2007-08-31

Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-08-31 Common Stock S 400 $39.9800 Disposed 230933.9595 Direct
2007-08-31 Common Stock S 2100 $40.0000 Disposed 228833.9595 Direct
2007-08-31 Common Stock S 300 $39.9800 Disposed 228533.9595 Direct
2007-08-31 Common Stock S 500 $39.9700 Disposed 228033.9595 Direct
2007-08-31 Common Stock S 900 $39.9600 Disposed 227133.9595 Direct
2007-08-31 Common Stock S 1600 $39.9500 Disposed 225533.9595 Direct
2007-08-31 Common Stock S 100 $40.0400 Disposed 225433.9595 Direct
2007-08-31 Common Stock S 200 $40.0300 Disposed 225233.9595 Direct
2007-08-31 Common Stock S 700 $40.0200 Disposed 224533.9595 Direct
2007-08-31 Common Stock S 200 $40.0100 Disposed 224333.9595 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 459.1917 Indirect
Common Stock 15543.5825 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.